推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

ANTIVIRAL RESEARCH

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 ANTIVIR RES最新评论:用 average() 求平均值 mean,用 stdev.s() 求标准差 sd,用 stdev.s()/count()^0.5 求标准误 sem。 (2021-12-30)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


ANTIVIRAL RESEARCH期刊基本信息Hello,您是该期刊的第79768位访客

基本信息 登录收藏
期刊名字ANTIVIRAL RESEARCHANTIVIRAL RESEARCH

ANTIVIR RES
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.6
50人评分
我要评分

声誉
8.7

影响力
6.4

速度
9.4

期刊ISSN0166-3542
微信扫码收藏此期刊
E-ISSN1872-9096
2022-2023最新影响因子
(数据来源于搜索引擎)
7.6 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:3.821
2022-2023自引率3.90%点击查看自引率趋势图
五年影响因子5.8
h-index 108
CiteScore
CiteScoreSJRSNIPCiteScore排名
17.001.7011.400
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q19 / 301
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Virology
Q112 / 75

期刊简介Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses: antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action; new or improved vaccines against viral infections of humans; assessments of drug and vaccine safety; evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures; identification and validation of new drug targets; laboratory animal models of viral diseases; pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.
期刊官方网站http://www.journals.elsevier.com/antiviral-research/
期刊投稿网址https://www.editorialmanager.com/AVR
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足ANTIVIRAL RESEARCH的语言要求,还能让ANTIVIRAL RESEARCH编辑和审稿人得到更好的审稿体验,让稿件最大限度地被ANTIVIRAL RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
出版商Elsevier
涉及的研究方向医学-病毒学
出版国家或地区NETHERLANDS
出版语言English
出版周期Monthly
出版年份1981
年文章数 158点击查看年文章数趋势图
Gold OA文章占比26.09%
研究类文章占比:
文章 ÷(文章 + 综述)
100.00%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:PHARMACOLOGY & PHARMACY
类别:SCIE
Q120/277
学科:VIROLOGY
类别:SCIE
Q16/36
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区2区1区
PHARMACOLOGY & PHARMACY
药学
2区3区2区
VIROLOGY
病毒学
1区3区2区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区2区
PHARMACOLOGY & PHARMACY
药学
4区4区2区
VIROLOGY
病毒学
3区2区2区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区2区
PHARMACOLOGY & PHARMACY
药学
3区4区2区
VIROLOGY
病毒学
4区4区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0166-3542%5BISSN%5D
平均审稿速度网友分享经验:
平均3.0个月
来源Elsevier官网:
平均9.6周
平均录用比例网友分享经验:
约25%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在ANTIVIRAL RESEARCH顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
在线出版周期来源Elsevier官网:
平均2.9周
期刊常用信息链接
同领域相关期刊 ANTIVIRAL RESEARCH期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 ANTIVIRAL RESEARCH中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
ANTIVIRAL RESEARCH上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    JOURNAL OF MEDICAL VIROLOGY10523.40
    REVIEWS IN MEDICAL VIROLOGY8418.70
    JOURNAL OF CLINICAL VIROLOGY9718.90
    PLoS Pathogens17411.20
    MICROBES AND INFECTION12913.30
    Journal of Virology27110.40
    VIRUS RESEARCH1048.90
    Virology Journal707.80
    INTERVIROLOGY575.20
    Influenza and Other Respiratory Viruses467.10
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE596770
    BIOMATERIALS510117
    BIOMEDICINE & PHARMACOTHERAPY457934
    Journal of Materials Chemistry B456232
    Frontiers in Pharmacology445261
    Frontiers in Immunology415700
    COLLOIDS AND SURFACES B-BIOINTERFACES401388
    JOURNAL OF ETHNOPHARMACOLOGY400602
    Frontiers in Oncology380134
    Acta Biomaterialia372389
  •  

    ANTIVIRAL RESEARCH ANTIVIRAL RESEARCH
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Ciliatoside A, isolated from Peristrophe japonica, inhibits HBsAg expression and cccDNA transcription by inducing autophagy

    Author: Fang, Ren; Ming, Tan; Ng, Jerome P. L.; Guo, Wu An; Yu, Yuan Si; Hui, Zhang; Hua, Ren Ji; Tao, Cheng Sheng; Juan, Zhang; Hong, Lo Hang; Wong, Vincent Kam Wai; Law, Betty Yuen Kwan; Juan, Chen
    Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105482
        PubMed      DOI
    2.Multiplication of defective Ebola virus in a complementary permissive cell line

    Author: Tong, Xian-Kun; Li, Heng; Yang, Li; Xie, Shi-Zhe; Xie, Sha; Gong, Ying; Peng, Cheng; Gao, Xiao-Xiao; Shi, Zheng-Li; Yang, Xing-Lou; Zuo, Jian-Ping
    Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105491
        PubMed      DOI
    3.Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster

    Author: Zhang, Ya-Nan; Zhang, Hong-Qing; Wang, Gui-Feng; Zhang, Zhe-Rui; Li, Jia-Qi; Chen, Xiao-Ling; Hu, Yan-Yan; Zeng, Xiang-Yue; Shi, Yu-Jia; Wang, Jing; Li, Ying-Hua; Li, Xiao-Dan; Wang, Chun-He; Zhu, Bing; Zhang, Bo
    Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105507
        PubMed      DOI
    4.PI3K/AKT-mediated autophagy inhibition facilitates mast cell activation to enhance severe inflammatory lung injury in influenza A virus- and secondary Staphylococcus aureus-infected mice

    Author: Tang, Yuling; Su, Ruijing; Gu, Qingyue; Hu, Yanxin; Yang, Hanchun
    Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105502
        PubMed      DOI
    5.A new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly

    Author: Hu, Longbo; Tang, Yongjie; Mei, Lingling; Liang, Mengdi; Huang, Jinxian; Wang, Xufei; Wu, Liping; Jiang, Jiajing; Li, Leyi; Long, Fei; Xiao, Jing; Tan, Long; Lu, Shaohua; Peng, Tao
    Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105509
        PubMed      DOI
    6.ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway

    Author: Yang, Qingyu; Wu, Chengyuan; Zhu, Guangyan; Ren, Fuli; Lin, Binbin; Huang, Rui; Hu, Xujuan; Zhao, Dingran; Peng, Ke; Wang, Qiongya; Huang, Chaolin; Zhang, Dingyu
    Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105498
        PubMed      DOI
    7.Targeting 7-dehydrocholesterol reductase against EV-A71 replication by upregulating interferon response

    Author: Wang, Huiqiang; Cui, Boming; Yan, Haiyan; Wu, Shuo; Wang, Kun; Yang, Ge; Jiang, Jiandong; Li, Yuhuan
    Journal: ANTIVIRAL RESEARCH. 2023; Vol. 209, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105497
        PubMed      DOI
    8.Identification of critical residues in the regulatory protein HBx for Smc5/6 interaction and hepatitis B virus production

    Author: He, Lili; Shen, Huanyu; Deng, Hui; Zhang, Xiaoyan; Xu, Yang; Shi, Chunwei; Ouyang, Zhuqing
    Journal: ANTIVIRAL RESEARCH. 2023; Vol. 211, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105519
        PubMed      DOI
    9.Influenza antivirals and their role in pandemic preparedness

    Author: Jones, Jeremy C.; Yen, Hui-Ling; Adams, Peter; Armstrong, Kimberly; Govorkova, Elena A.
    Journal: ANTIVIRAL RESEARCH. 2023; Vol. 210, Issue , pp. -. DOI: 10.1016/j.antiviral.2022.105499
        PubMed      DOI
    10.Development of highly effective LCB1-based lipopeptides targeting the spike receptor-binding motif of SARS-CoV-2

    Author: Zhu, Yuanmei; Li, Min; Liu, Nian; Wu, Tong; Han, Xuelian; Zhao, Guangyu; He, Yuxian
    Journal: ANTIVIRAL RESEARCH. 2023; Vol. 211, Issue , pp. -. DOI: 10.1016/j.antiviral.2023.105541
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共22条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451